For laboratory research use only. Not for human consumption.
For laboratory research use only. Not for human consumption.
LL-37 (human cathelicidin antimicrobial peptide / hCAP-18 C-terminal fragment) is an amphipathic 37-amino-acid host defense peptide engineered to target microbial membranes and modulate innate immune pathways. Adopting an α-helical conformation, LL-37 neutralizes bacterial lipopolysaccharide (LPS) endotoxins, binds Formyl Peptide Receptor-Like 1 (FPRL-1 / FPR2), and triggers P2X7 receptor signaling to direct cell migration, angiogenesis, and tissue repair cascades.
€42.00
LL-37 (antimicrobial peptide) is the primary active cleavage fragment of human cathelicidin antimicrobial protein 18 (hCAP-18). Comprising 37 amino acids beginning with two N-terminal leucine residues (Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser), LL-37 serves as an essential endogenous host defense peptide operating across central innate immunomodulatory and tissue repair systems.
Characterized by a net positive charge (+6 at physiological pH) and an amphipathic α-helical tertiary structure, LL-37 directly binds negatively charged bacterial lipopolysaccharides (LPS), neutralizing endotoxin-induced toll-like receptor 4 (TLR4) inflammatory cascades. Concurrently, LL-37 agonizes Formyl Peptide Receptor-Like 1 (FPRL-1 / FPR2) and P2X7 purinergic receptors, driving endothelial cell tubulogenesis, keratinocyte re-epithelialization, and regulated leukocyte recruitment.
Batch-verified for high analytical purity at Modern Aminos, LL-37 is offered in a pre-measured 5MG lyophilized dry powder format in a 2R glass vial. Researchers evaluating host defense kinetics, endotoxin binding capacity, and extracellular matrix remodeling utilize LL-37 alongside complementary tissue-repair reference standards available on the site, such as KPV, BPC-157, TB-500, and GHK-Cu.
| Compound Name | LL-37 (Human Cathelicidin Fragment) |
|---|---|
| Quantity / Formats Offered | 5MG Lyophilized Dry Powder in 2R Glass Vial |
| Peptide Sequence | Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser |
| Synonyms / Alt Names | LL-37, Cathelicidin, hCAP-18 (104-140), FALL-39 active peptide fragment |
| CAS Number | 154780-71-9 |
| Chemical Formula | C205H340N60O53 |
| Molecular Weight | 4493.33 g/mol |
| IUPAC Name | Human cathelicidin C-terminal 37-amino-acid peptide fragment |
| InChIKey | Protected Peptide Sequence Matrix |
| SMILES Code | Protected Peptide Sequence Matrix |
The biochemical pathways and cellular targets of LL-37 in laboratory research include:
When evaluating research efficacy and published scientific literature for LL-37:
To evaluate host defense mechanisms, immunomodulatory pathways, and tissue repair kinetics, researchers compare LL-37 against alternative reference standards available at Modern Aminos:
In cellular inflammation and host defense research, structural targeting determines pathway activation:
| Compound / Reference | Chemical Structure & Class | Core Mechanism of Action | Research Focus & Profile |
|---|---|---|---|
| LL-37 | 37-Amino-Acid Amphipathic Cathelicidin Peptide | Binds LPS endotoxins, disrupts microbial membranes via pore formation, and agonizes FPR2/P2X7 receptors | Focuses on host defense, LPS neutralization, cell migration, re-epithelialization, and microvascular angiogenesis |
| KPV | α-MSH C-Terminal Tripeptide (Lys-Pro-Val) | Inhibits NF-κB nuclear translocation to downregulate pro-inflammatory cytokines (TNF-α, IL-6) | Focuses on targeted mucosal barrier anti-inflammation, gut epithelial cell stabilization, and acute cytokine dampening |
| BPC-157 | Synthetic 15-Amino-Acid Gastric Cytoprotective Peptide | Upregulates VEGFR2 expression, activates FAK/Paxillin pathways, and modulates NO synthesis | Focuses on cytoprotective tissue repair, tendon/ligament fibroblast migration, and gut mucosal healing |
| GHK-Cu | Copper-Chelated Tripeptide (Gly-His-Lys) | Upregulates collagen, elastin, and extracellular matrix (ECM) gene networks while stimulating SOD1 antioxidant activity | Focuses on tissue remodeling, extracellular matrix synthesis, angiogenesis, and anti-inflammatory signaling |
Yes, Modern Aminos is a highly trusted vendor for high-purity research chemicals and reference peptides. Every batch of LL-37 undergoes strict third-party analytical testing (including HPLC and Mass Spectrometry) to verify minimum 98%+ chemical purity, exact 37-amino-acid sequence fidelity, correct molecular weight (4493.33 g/mol), and complete absence of heavy metals or synthesis impurities.
LL-37 is the sole human cathelicidin antimicrobial peptide. It is derived from the enzymatic cleavage of the pro-protein hCAP-18 and consists of 37 amino acids starting with two leucine residues.
LL-37 adopts an amphipathic α-helical structure that interacts electrostatically with negatively charged microbial phospholipid membranes. It inserts into the lipid bilayer to form toroidal pores, disrupting membrane potential and causing cell lysis.
LL-37 directly binds bacterial LPS endotoxins, sequestering them from TLR4 receptor complexes. This inhibits downstream NF-κB signaling and suppresses the release of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.
LL-37 acts as an agonist for Formyl Peptide Receptor-Like 1 (FPRL-1 / FPR2) and purinergic P2X7 receptors, stimulating MAPK/ERK cascades that regulate cell migration, re-epithelialization, and microvascular tubulogenesis.
LL-37 combines direct microbial membrane perturbation with FPR2-mediated chemotaxis and LPS neutralization. KPV focuses primarily on NF-κB anti-inflammatory signaling.
Modern Aminos utilizes High-Performance Liquid Chromatography (HPLC) to confirm active chemical purity exceeding 98% and Mass Spectrometry (MS) to verify exact molecular weight (4493.33 g/mol) and 37-amino-acid sequence identity prior to batch release.
Lyophilized LL-37 5MG glass vials should be stored tightly sealed in a cool, dry environment (15°C to 25°C) or refrigerated for long-term preservation. Protect from direct heat, light exposure, and atmospheric moisture to maintain solid-state peptide stability.
DISCLAIMER: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research use only. They are not approved for human consumption by the Food and Drug Administration (FDA). No products are approved for oral, sublingual, nor in vivo use. These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.
Modern Aminos is the best place to buy peptides online. We are a trusted Research Chemicals vendor with formulations that meet industry standards and comply with quality regulations in Europe, USA, and Canada to ensure product safety and efficiency.
Our products are routinely and rigorously tested for purity, with COAs verifiable through third-party laboratory testing services.
We also maintain reliable customer services to facilitate smooth consumer experience from pre-sale inquiries to after sales concerns. For questions about our products, you may contact us at support@modernaminos.eu
The products available for purchase from Modern Aminos are intended solely for research and laboratory use. These compounds are not designed for human consumption or the diagnosis, treatment, cure, or prevention of any disease or condition.
All customers are presumed to be research professionals who understand that any compounds purchased from Modern Aminos will be handled in accordance with safety protocols mandated by their respective regulatory agencies.
Modern Aminos does not endorse the use of these products in a non-clinical setting or any other non-laboratory-based operations. By purchasing any of these compounds, you acknowledge that you will use them for legitimate research purposes only.
Modern Aminos shall not be held liable for injuries or damages resulting from the handling or use of our products. If you do not agree with these conditions, we advise you not to proceed with the purchase of any research compounds from our company.
All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent for research purposes only. Research supplies (e.g., syringes, bacteriostatic water) are not included. No dosing instructions are provided. We adhere to all local and state laws around Research Only Chemical sales. We are not a pharmacy, nor do we promote or provide any advice for human or animal consumption. Please review our terms and conditions carefully before making a purchase on our website.
You must be 21+ and a licensed research professional
By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above
